Irritant contact dermatitis (ICD) is characterized ling cells and the epidermal differentiation markers by mild erythema, itosis or dyskeratosis, (involucrin, epidermal fatty acid binding protein chapping and fissures (1) and is pathogenetically
(E-FABP) ) in the irritant reaction thought to be the results of cumulative exposure to single 4-h exposure to SDS (5%) (w/v) (4) . An SDS irritants which may be o f various origin (2). Daily concentration of 0.2% caused a significant increase exposure to these irritants cannot be standardized. TEWL any change in To study the pathogenesis of ICD, experimental epidermal proliferation and different! models in men are needed. In vivo models have pared to the normal skin was seen (5) centration of SDS was chosen in th SDS-exposed skin and the triamcinolontreated group versus its vehicle; (B) of the SDS-exposed skin and the tretinoin-treated group versus its vehicle; (C) of the SDS-exposed skin and the calcipotriol-treated group versus its vehicle. inflammatory conditions (8, 9) , is downregulated to the normal levels in the steroid-treated epider mis (7) . The vitamin A metabolite, retinoic-acid, is es sential to normal differentiation of many tissues including skin. Retinoic acid and synthetic retin oids are used in the treatment o f acne (10), pso riasis (11) and certain malignancies (12). Several studies in mouse and man indicate that topical re tinoic acid speeds repair of skin damage due to ultraviolet radiation (13, 14). Effects of retinoids on the epidermis include modification of keratin expression (15) and inhibition of cross-linked cornified envelope synthesis (16). Retinoids can either stimulate or inhibit cell growth (17).
Vitamin D 3 derivatives are the recent therapeutic modalities in psoriasis.They are known to affect the epidermal growth. treatment by topical steroid (7) . Furthermore, the expression of skin-derived antileukoproteinase (SKALP), an elastase inhibitor which is induced in olon-treated group versus its vehicle; (B) o f the SDS-exposed skin and the tretinoin-treated group versus its vehicle; (C) o f the SDS-exposed skin and the calcipotriol-treated group versus its vehicle. 
Administration of vitamin D 3 to cultured keratinocytes causes suppression of cell proliferation and enhancement of cell differen tiation (18). Vitamin D 3 derivatives can modulate inflammatory processes. When T-lymphocyte cul-
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scoring and transepidermal water loss (T E W L) measurements
Visual grading and TEWL were assessed at: day 1 to day 7, day 10 and day 14. TEWL was measured with a Tewameter™ 210 (Courage & Khazaka, Cologne), according to standard guidelines (29). Room temperature varied from 20°C to 25°C and relative humidity from 40% to 60%. Clinical scor ing (erythema) was graded visually: 0, no response; 1, slight, patchy redness; 2, diffuse mild redness; 3, moderate redness; 4, intense redness; 5, intense redness with edema.
Biopsy procedures
A total of 40 punch biopsies (3 mm diameter) were taken: 16 biopsies at day 2 to examine the histology of the triamcinolon-treated group, the tretinoin-treated group, the vehicle-treated group and the SDS-exposed group; 24 biopsies at day 4 for these 4 groups and the calcipotriol-treated group and its vehicle. Thus, 4 biopsies per treat ment/per timepoint. After 4 h fixation in form alin, the samples were embedded in paraffin, and sectioned at 6 pm for immunohistochemical staining.
Immunohistochemical methods
The biopsies were stained with the following antibodies according to standard procedures, deies ( 
Results
Clinical grading and TEWL measurements
Repetitive exposure of human skin to SDS (0.2%) induced an increase in erythematous reaction (Fig.  1 ) and in TEWL measurement (Fig. 2) , enhancing in intensity up to day 4, then gradually decreasing to day 14. No significant difference in erythema or in TEWL was found between the triamcinolon acetonide, tretinoin or calcipotriol treated groups versus their vehicles.
Histology and immunohistochemistry H&E staining. The exposed skin of day 4 showed mild to moderate parakeratosis, hypergranulosis, acanthosis, exocytosis and moderate perivascular infiltrate composed of mostly mononuclear cells and some eosinophils. The sections of the triamci nolon acetonide cream treated skin demonstrated a slightly milder perivascular infiltrate, less para keratosis and less acanthosis as compared to its vehicle (Fig. 3) . hides, was seen (Figs. 5a, 6a) .
No difference between the tretinoin-or calcipotriol-treated skin and their vehicles was observed with respect to hypergranulosis, pa rakeratosis, spongiosis, acanthosis and perivas cular infiltrate. proliferation. The response of un treated skin, repetitively exposed to SDS, was characterized by an increase in the number of M IB-1 -positive nuclei from 78±22 per mm a maximum of 180±50 4 after stimulation. The (mean number of proliferative cells o f all groups was also enhanced up to day 4. A mar cu it (/;==().02) in number of cycling cells/mm (72±14) of the tri amcinolon acetonide treated sections was ob served as compared to the other exposed sites (Fig 4a). No significant difference in the number of cycling cells/mm between the tretinoin-or cal-
Epidermal differentiation. To study the effect of the verum drugs on epidermal differentiation in our model, we investigated the expression of invol- (Fig. 4b, c) . There was no difference in the expression of involucrin and E-shown).
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Mn expression of the triamcinolone-treated group ver-Calcipotriol did not lead to modulation of the episus its vehicle are illustrated in Fig. 7 .
Discussion
dermal response after exposure to SDS with the exception of an increase in TEWL. This may be due to its vehicle, which is known to be irritant. At day 5 after challenge, a small, non-significant The induction of irritant reactions by repetitive ex-increase (/?=0.18) in TEWL of the vehicle of calciposure to SDS and the repair with or without potriol-treated sites versus the SDS exposed sites treatment were studied using visual scoring, was found. In our present study, repetitive ex-TEWL and markers of epidermal proliferation posure to SDS for 5 days induced an increase in and differentiation. Repetitive exposure to SDS number of cycling cells and the expression of involcauses an increase in erythema and in TEWL to a ucrin and E-FABP. Treatment with retinoic acid or maximum at day 4, then gradually decreases up calcipotriol in this irritant skin did not show any to day 14 after the first challenge. The repetitive alteration with respect to these parameters. exposure to SDS not only induced histological Topical steroids may influence irritant reactions. changes to the epidermal cell compartment (para-Skin may deal with repetitive irritant stimuli with keratosis, perivascular mononuclear infiltrates) adaptation, regeneration or disease (irritant conbut also upregulated the expression of markers of tact dermatitis). Intervention may influence the inepidermal differentiation and proliferation, corre-flammatory response (7) and consequently may sponding to a hyperproliferative skin. Treatment prevent tissue damage as caused by the inflamof skin irritation by triamcinolon acetonide, reti-mation, but may also hamper repair processes by noic acid or calcipotriol did not improve the clin-its anti-mitotic activity. Therefore, it cannot be ical scores in this model. Neither significant de concluded from our data that topical steroids are crease in erythema scoring nor decrease in TEWL beneficial to the skin. was observed. In contrast to this clinical finding, Single exposure tests are inadequate for predicwe found a statistically significant reduction of the tion of the effect of treatment modalities. Cumulanumber of cycling cells in the triamcinolone-tive exposure models or clinical studies with stantreated skin sites versus the other exposed sites. In dardized exposure are needed. addition, the expression of involucrin and E-FABP was also downregulated in the triamcinolontreated skin as compared to that treated with its vehicle.
The fact that triamcinolone acetonide cream in duces a reduction of cycling cells may indicate that triamcinolon acetonide cream causes less irritation or delays repair. In contrast to other studies (31, 32) in which topical steroids are believed to be diminish the erythematous response of SDS ex posed skin, we could neither demonstrate this ef fect in this model nor in a previous work (33).
Treatment with retinoic acid did not lead to any change in visual scoring, TEWL and modulation of the epidermal response to SDS, as compared to its vehicle. Adding retinoic acid to keratinocytes in vitro reduces transglutaminase activity and consequently may inhibit terminal concomitant cor srentiation and envelope formation (34). Retinoic acid can induce epidermal hyperprolifer ation and increase in transglutaminase immunoreactivity when applied topically for 4 months to photoaged human skin (35). Furthermore, retinoic acid can increase the expression of transglutamina se, loricrin, involucrin, filaggrin when applied to normal human skin for 4 days under occlusion (36). Here, we found no alterations in involucrinand E-FABP-expression at the tretinoin-treated sites. The exact mechanism of retinoic acid in the SDS-induced skin irritation remains unknown.
